Analysis of 'Component-Target-Pathway' and Mining of Potential Biomarkers for Yinchenhao Decoction Combined with Lamivudine in the Treatment of Alcoholic Liver Disease and Its Derived Disorders
Yinchenhao Decoction combined with Lamivudine may treat ALD through multiple components acting on multiple targets and pathways, primarily via IL-6-driven inflammation control and nuclear receptor modulation, and IL-6 appears to be a useful biomarker for monitoring ALD progression under this combined therapy.